Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (1): 34-39.doi: 10.6040/j.issn.1671-7554.0.2020.0513

Previous Articles     Next Articles

Clinical analysis of outcomes of 84 pregnant women with pulmonary hypertension

JIA Mingwang, LIAO Guangyuan, XIONG Mingmei, XU Wenting, WANG Yinling, WANG Yichun   

  1. Department of Critical Care Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, Guangdong, China
  • Published:2021-01-09

Abstract: Objective To analyze the clinical data of 84 pregnant women with pulmonary hypertension(PH)retrospectively, and to provide evidence for the treatment plan and prognosis assessment of the patients. Methods A total of 84 pregnant women with PH who hospitalized in The Third Affiliated Hospital of Guangzhou Medical University from October 2017 to September 2019 were enrolled. The difference of clinical data, including age, gestational age, WHO functional class, pulmonary artery systolic pressure, mode of delivery, inpatient days, ICU admission, cost of treatment, the incidence of complications, maternal death and fetal death, in idiopathic pulmonary arterial hypertension(iPAH)group, pulmonary arterial hypertension associated with congenital heart disease(CHD-PAH)group, pulmonary hypertension caused by left heart disease(LHD-PH)group and pulmonary arterial hypertension associated with other disease(oPAH)group were analyzed. Then the patients were grouped by three ways, including clinical conditions, pulmonary artery systolic pressure and World Health Organization(WHO)functional class, and the prognosis was comparied. The One-Way ANOVA test, Kruskal-Wallis H test and Fishers exact test analyses were mainly used for statistical analysis of data. Results Most of pregnant women with PH were iPAH, CHD-PAH, LHD-PH, and oPAH types. Grouped by clinical conditions, WHO functional class and pulmonary artery systolic pressure were statistically different on the whole for the iPAH, CHD-PAH, LHD-PH, and oPAH groups(both P<0.001). The rates of mortality in the four groups were statistically different on the whole, in which iPAH group was higher than CHD-PAH group(P=0.006), LHD-PH group(P<0.001)and oPAH group(P=0.004). The ICU admission in the four groups were statistically different on the whole, in which iPAH group was higher than LHD-PH group(P=0.001)and oPAH group(P=0.009). Grouped by pulmonary arterial systolic blood pressure, the mortality were statistically different on the whole for ≥90 mmHg group, 70-89 mmHg group, 50-69 mmHg group and 30-49 mmHg group(P<0.001), in which ≥90 mmHg group was higher than 30-49 mmHg group(P<0.001)and 50-69 mmHg group(P=0.015); the ICU admissions in the four groups were statistically different on the whole(P<0.001), in which 90 mmHg group was higher than 30-49 mmHg group(P<0.001)and 50-69 mmHg group(P=0.044), and 70-89 mmHg group was higher than 30-49 mmHg group(P<0.001). Grouped by WHO function, the mortality, ICU admission and hospitalization costs were statistically different on the whole(P=0.013,P<0.001,P=0.008),in which WHO function Ⅳ grade group was higher than WHO function Ⅰ grade group(P=0.046,P=0.003,P=0.040). Conclusion Outcomes of pregnant women with PH are poor in iPAH type, the preoperative preparation, maybe extracorporeal membrane oxygenation(ECMO)should be made. The clinical conditions, pulmonary artery systolic pressure, and WHO functional class should be considered in assessment of the patients outcomes.

Key words: Pregnancy, Pulmonary hypertension, Outcomes, Management

CLC Number: 

  • R574
[1] Farber HW, Loscalzo J. Pulmonary arterial hypertension[J]. N Engl J Med, 2004, 351(16): 1655-1665.
[2] Lan N, Massam B, Kulkarni S, et al. Pulmonary arterial hypertension: pathophysiology and treatment[J]. Diseases, 2018, 6(2): 38. doi:10.3390/diseases6020038.
[3] Sahay S. Evaluation and classification of pulmonary arterial hypertension[J]. J Thorac Dis, 2019, 11(suppl 14): S1789-S1799.
[4] Obi(ˇoverc)an SG, Cleary KL. Pulmonary arterial hypertension in pregnancy[J]. Semin Perinatol, 2014, 38(5): 289-294.
[5] Chakravarty EF, Khanna D, Chung L. Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease[J]. Obstet Gynecol, 2008, 111(4): 927-934.
[6] 中华医学会心血管病学分会肺血管病学组, 中华心血管病杂志编辑委员会. 中国肺高血压诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(12): 933-964.
[7] Kah Teik C, Ahmad MF, Soon Leong Y, et al. Pulmonary hypertension complicating systemic sclerosis: a successful pregnancy outcome[J]. J Obstet Gynaecol, 2017, 37(5): 677-678.
[8] Rashidi F, Sate H. Pregnancy outcome in a pregnant patient with idiopathic pulmonary arterial hypertension: a case report and review of the literature[J]. J Med Case Rep, 2018, 12: 31. doi:10.1186/s13256-017-1547-1.
[9] Meng ML, Landau R, Viktorsdottir O, et al. Pulmonary hypertension in pregnancy: a report of 49 cases at four tertiary north American sites[J]. Obstet Gynecol, 2017, 129(3): 511-520.
[10] Thomas E, Yang J, Xu JJ, et al. Pulmonary hypertension and pregnancy outcomes: insights from the national inpatient sample[J]. J Am Heart Assoc, 2017, 6(10): e006144. doi:10.1161/jaha.117.006144.
[11] Lima FV, Yang J, Xu JJ, et al. National trends and in-hospital outcomes in pregnant women with heart disease in the United States[J]. Am J Cardiol, 2017, 119(10): 1694-1700.
[12] Schlichting LE, Insaf TZ, Zaidi AN, et al. Maternal comorbidities and complications of delivery in pregnant women with congenital heart disease[J]. J Am Coll Cardiol, 2019, 73(17): 2181-2191.
[13] Sliwa K, van Hagen IM, Budts W, et al. Pulmonary hypertension and pregnancy outcomes: data from the registry of pregnancy and cardiac disease(ropac)of the European Society of Cardiology[J]. Eur J Heart Fail, 2016, 18(9): 1119-1128.
[14] Sun X, Feng J, Shi J. Pregnancy and pulmonary hypertension: an exploratory analysis of risk factors and outcomes[J]. Medicine(Madr), 2018, 97(44): e13035. doi:10.1097/md.0000000000013035.
[15] Keepanasseril A, Pillai A, Yavanasuriya J, et al. Outcome of pregnancies in women with pulmonary hypertension: a single-centre experience from South India[J]. BJOG: Int J Obstet Gynaecol, 2019, 126: 43-49. doi:10.1111/1471-0528.15681.
[16] Martínez MV, Rutherford JD. Pulmonary hypertension in pregnancy[J]. Cardiol Rev, 2013, 21(4): 167-173.
[17] Duarte AG, Thomas S, Safdar Z, et al. Management of pulmonary arterial hypertension during pregnancy[J]. Chest, 2013, 143(5): 1330-1336.
[18] Collins RT II, Chang D, Sandlin A, et al. National in-hospital outcomes of pregnancy in women with single ventricle congenital heart disease[J]. Am J Cardiol, 2017, 119(7): 1106-1110.
[19] Adachi S, Shimokata S, Yoshida M, et al. Addition of a bilateral access form of peripheral extracorporeal membrane oxygenation rescued a patient with idiopathic pulmonary arterial hypertension who developed circulatory collapse immediately after childbirth[J]. Pulm Circ, 2020, 10(1): 204589402091014. doi:10.1177/2045894020910140.
[20] Phoophiboon V, Jaimchariyatam N, Suphot S, et al. Successful multimodality management of severe pulmonary arterial hypertension during pregnancy with VA-ECMO and atrial septostomy using stent[J]. BMJ Case Rep, 2019, 12(12): e231916. doi: 10.1136/bcr-2019-231916.
[21] Memon HA, Safdar Z, Goodarzi A. Use of extracorporeal membrane oxygenation in postpartum management of a patient with pulmonary arterial hypertension[J]. Case Rep Pulmonol, 2018: 7031731. doi: 10.1155/2018/7031731.
[22] Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Rev Esp Cardiol(Engl Ed), 2016, 69(2): 177. doi: 10.1016/j.rec.2016.01.002.
[23] Stevenson MD, Macdonald FC, Langley J, et al. The cost-effectiveness of bosentan in the United Kingdom for patients with pulmonary arterial hypertension of WHO functional class III[J]. Value Health, 2009, 12(8): 1100-1105.
[24] Simonneau G, Galiè N, Jansa P, et al. Long-term results from the EARLY study of bosentan in WHO functional class II pulmonaryarterial hypertension patients[J]. Int J Cardiol, 2014, 172(2): 332-339.
[25] Bhogal S, Mukherjee D, Banerjee S, et al. Current trends and future perspectives in the treatment of pulmonary hypertension: WHO Group II-V[J]. Curr Probl Cardiol, 2018, 43(5): 217-231.
[1] Ruifang WU,Changzhong LI. Status and progress of female fertility protection [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 1-7.
[2] XU Xiaofen, ZHU Xiao, MA Wei, LI Na. Influencing factors of cancer pain management disorder in 123 cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 119-124.
[3] Qun LU,Lulu ZHAO. Progress on assisted reproductive technology for women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertilitysparing treatment [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 35-41.
[4] Chao PENG,Yingfang ZHOU. Progress on the medical treatment of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 20-25.
[5] Xiaofang YI,Jihua HUANG. Patient education and proper management of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 32-35.
[6] AILI Aixingzi,Zhengyu GUO,Xiaofei ZHANG. Latest research advances of high intensity focused ultrasound treatment for adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 36-42.
[7] WU Richao, LIU Hong, WANG Ze, GAO Shanshan, LI Xiufang, SHI Yuhua. Pregnancy outcomes of in vitro fertilization-intracytoplasmic sperm injection-embryo transfer in women 40 years and above [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 35-39.
[8] CAO Danfeng, LIU Zonghua, WANG Junzhi, ZHANG Guoxiang. The independent and cumulative associations of childhood household dysfunction with depressive symptoms during pregnancy [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 97-101.
[9] CHE Guowei. It is necessary for enhanced recovery after surgery to keep pace with the times [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 17-22.
[10] GAO Shugeng. Application of enhanced recovery after surgery in perioperative management of lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 1-10.
[11] HAN Dingpei, YAN Yue, CAO Yuqin, SUN Xin, HU Yanxia, WANG Minxian, LUO Yan, SHI Yongmei, XIE Qing, HANG Junbiao, LI Hecheng. Expert consensus of Ruijin Hospital on the concept of enhanced recovery after surgery in the clinical practice of thoracic surgery [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 11-16.
[12] ZHANG Xuan, WU Liuliu, HAN Jing, CHEN Qingyi, MAO Fangxiang, WANG Juan, SUN Jiwei, ZHANG Guoxiang, CAO Danfeng, CAO Fenglin. Reliability and validity test of the Chinese Body Understanding Measure for Pregnancy Scale [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 87-91.
[13] LI Yan, LIU Jing, LI Juan, YANG Qiuhong. Clinical characteristics and placental pathology of bloodstream infection in 50 pregnant women [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 48-54.
[14] Kefang WANG,Chen WU. Dilemmas and thoughts on solutions of adherence to chronic disease management [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 124-129.
[15] ZHANG Jianping, LUO Yinger. Application progress of anticoagulant drugs in the treatment of recurrent adverse pregnancy [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 14-19.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] ZHENG Min,HAO Yue-wei,LIU Xue-ping,ZHAO Ting-ting. Relationship between the HPA-2 and Kozak sequence polymorphism of platelet membrane glycoprotein and cerebral infarction[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(3): 292 -295 .
[2] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(8): 828 -830 .
[3] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(9): 5 -6 .
[4] NIU Rui,LIU Bo,SHAO Ming-ju,WANG Wei. mRNA expression of lunx in regional lymph nodes of non-small cell lung cancer and its correlation with prognosis[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(9): 884 -885 .
[5] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(10): 995 .
[6] JIANG Hong-ju,LI Run-zhi, WANG Ying,XU Dong-mei,ZHANG Mei,ZHANG Yun,LI Ji-fu. Relationship between the plasma level of matrix metalloproteinase-9 and structural characteristics of plaques and percutaneous coronary intervention [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(10): 966 -970 .
[7] ZHANG Jie,LI Zhen-hua,SUN Jin-hao,BAO Li-hua,LIU Yue-peng. Protective effects of the invariable magnetic field on oxidative injured Schwann cells[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(3): 229 -232 .
[8] WANG Shu-qin,QI Feng,WU Jian-bo,SUN Bao-zhu. Effect of calcium in ropivacaine-induced smooth muscle contraction of the aorta in rats in vitro[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(8): 773 -776 .
[9] TENG Xue-ren,ZHAO Yong-sheng,HU Guang-liang,ZHOU Lun,LI Jian-min. Characteristics of microcosmic changes following tendon allograft transplantation preserved by two methods under light microscopy and transmission electron microscopy[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(10): 945 -950 .
[10] . Association of  killerimmunoglobulinlike receptors in the decidua and unexplained early recurrent spontaneous abortion[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(12): 81 -85 .